Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
BIOTECH-IGG ApS
APS
Bankrupt
CVR 32099807
Arne Jacobsens Allé 7, 2300
København S
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2009 · 17 years old
2 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
BIOTECH-IGG ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (6)
AE
Anders Edvardsson
Chief Executive Officer
Chief Executive Officer
2017 – 2017
AJ
Alistair John Hurst
Management
Management
2009 – 2012
JK
Johan Karl-Herbert Backman
Deputy
Deputy
2017 – 2021
MC
Michael Christian Torben Serring
Unofficial title
Unofficial title
2021 – 2021
KA
Kirstin Ann Kriz
Management
Management
2012 – 2017
GH
Glenn Hugo Renhult
Management
Management
2017 – 2021
Board of directors
Non-executive oversight
Name
Role
Member since
Former (12)
ES
Edvard Skodic
Board of Directors
Board of Directors
2015 – 2017
AJ
Alistair John Hurst
Board of Directors
Board of Directors
2017 – 2017
LO
Lars Olof Artur Hansson
Board of Directors
Board of Directors
2011 – 2015
MÅ
Mats Åke Andersson
Chairman
Chairman
2017 – 2017
MA
Margaret Anne Hurst
Board of Directors
Board of Directors
2009 – 2011
MA
Margareta Anna Kriz
Board of Directors
Board of Directors
2009 – 2014
GH
Glenn Hugo Renhult
Board of Directors
Board of Directors
2017 – 2021
GA
Georg Aram Soma
Board of Directors
Board of Directors
2017 – 2017
AS
Anders Simon Ulric Aspegrén
Board of Directors
Board of Directors
2015 – 2017
MK
Margareta Krook
Board of Directors
Board of Directors
2009 – 2017
FQ
Faridoon Qazi
Board of Directors
Board of Directors
2015 – 2017
SB
Stefan Bo Erik Nyman
Board of Directors
Board of Directors
2017 – 2017
Shareholders
As of last annual report
Biotech-IgG AB (publ) — 100%
Glenn Hugo Renhult — 100%
100%
Shareholder
Type
Ownership
Votes
Since
Biotech-IgG AB (publ)
Individual
100%
100%
2009
Glenn Hugo Renhult
Individual
100%
100%
2018
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on BIOTECH-IGG ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network